Presence of mitogen-activated protein kinase in retinal Müller cells and its neuroprotective effect ischemia-reperfusion injury

Hiroshi Akiyama, Toru Nakazawa, Masahiko Shimura, Hiroshi Tomita, Makoto Tamai

研究成果: Article査読

38 被引用数 (Scopus)

抄録

The purpose of this study was to determine whether the mitogen-activated protein kinase (MAPK) signaling pathway in the retina plays a neuroprotective role against ischemia-reperfusion injury. Western blot analysis showed that the MAPK activity was markedly increased within an hour after ischemia-reperfusion and subsequently decreased. Immunohistochemical studies revealed that MAPK was expressed mainly in the retinal Müller cells (RMCs). Pre-ischemic intravitreal administration of a MAPK inhibitor, U0126, increased the number of ganglion cell deaths induced by ischemia-reperfusion injury. We conclude that the MAPK activated in the RMCs protects ganglion cells against the ischemia-reperfusion injury through glia-neuronal interaction.

本文言語English
ページ(範囲)2103-2107
ページ数5
ジャーナルNeuroReport
13
16
DOI
出版ステータスPublished - 2002 11 15

ASJC Scopus subject areas

  • Neuroscience(all)

フィンガープリント 「Presence of mitogen-activated protein kinase in retinal Müller cells and its neuroprotective effect ischemia-reperfusion injury」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル